Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway
Nausea hit 45% of participants
However, although the solution is simple, it is by no means easy
Semaglutide is a specific peptide designed to mimic GLP-1, while peptide therapy includes a wider range of compounds with different functions
The American Diabetes Association emphasizes the importance of individualized treatment approaches that balance therapeutic benefits with tolerability and patient preferences
Inicialmente, se comercializaron monoagonistas de GLP-1R que tuvieron como objetivo el tratamiento de la diabetes tipo2, explotando el efecto incretnico y su carcter glucosa-dependiente, a lo que se aadi la accin reductora del peso corporal y sus efectos sobre comorbilidades asociadas1,3,5